Baotou Dongbao Bio-Tech Co.,Ltd

SZSE:300239 Rapporto sulle azioni

Cap. di mercato: CN¥3.2b

Baotou Dongbao Bio-TechLtd Salute del bilancio

Salute finanziaria criteri di controllo 5/6

Baotou Dongbao Bio-TechLtd has a total shareholder equity of CN¥1.7B and total debt of CN¥474.7M, which brings its debt-to-equity ratio to 27.6%. Its total assets and total liabilities are CN¥2.7B and CN¥996.9M respectively. Baotou Dongbao Bio-TechLtd's EBIT is CN¥99.5M making its interest coverage ratio -22.1. It has cash and short-term investments of CN¥638.8M.

Informazioni chiave

27.6%

Rapporto debito/patrimonio netto

CN¥474.69m

Debito

Indice di copertura degli interessi-22.1x
ContantiCN¥638.83m
Patrimonio nettoCN¥1.72b
Totale passivitàCN¥996.93m
Totale attivitàCN¥2.72b

Aggiornamenti recenti sulla salute finanziaria

Nessun aggiornamento

Recent updates

Market Might Still Lack Some Conviction On Baotou Dongbao Bio-Tech Co.,Ltd (SZSE:300239) Even After 37% Share Price Boost

Oct 08
Market Might Still Lack Some Conviction On Baotou Dongbao Bio-Tech Co.,Ltd (SZSE:300239) Even After 37% Share Price Boost

We Like These Underlying Return On Capital Trends At Baotou Dongbao Bio-TechLtd (SZSE:300239)

Oct 01
We Like These Underlying Return On Capital Trends At Baotou Dongbao Bio-TechLtd (SZSE:300239)

Baotou Dongbao Bio-TechLtd's (SZSE:300239) Dividend Will Be Reduced To CN¥0.022

May 27
Baotou Dongbao Bio-TechLtd's (SZSE:300239) Dividend Will Be Reduced To CN¥0.022

Sentiment Still Eluding Baotou Dongbao Bio-Tech Co.,Ltd (SZSE:300239)

Feb 28
Sentiment Still Eluding Baotou Dongbao Bio-Tech Co.,Ltd (SZSE:300239)

Analisi della posizione finanziaria

Passività a breve termine: 300239's short term assets (CN¥1.3B) exceed its short term liabilities (CN¥442.3M).

Passività a lungo termine: 300239's short term assets (CN¥1.3B) exceed its long term liabilities (CN¥554.6M).


Storia e analisi del rapporto debito/patrimonio netto

Livello di debito: 300239 has more cash than its total debt.

Riduzione del debito: 300239's debt to equity ratio has increased from 7.1% to 27.6% over the past 5 years.

Copertura del debito: 300239's debt is well covered by operating cash flow (20.7%).

Copertura degli interessi: 300239 earns more interest than it pays, so coverage of interest payments is not a concern.


Bilancio


Scoprire le aziende sane